120 related articles for article (PubMed ID: 31205223)
1. Primary Cutaneous Diffuse Large B-Cell Lymphoma With KMT2A-MLLT3: An Infantile Case Study.
Hiroki H; Yoshimi A; Kato K; Yanai T; Koike K
J Pediatr Hematol Oncol; 2019 Nov; 41(8):657-658. PubMed ID: 31205223
[No Abstract] [Full Text] [Related]
2. MLL/KMT2A translocations in diffuse large B-cell lymphomas.
Gindin T; Murty V; Alobeid B; Bhagat G
Hematol Oncol; 2015 Dec; 33(4):239-46. PubMed ID: 25131304
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal ATP5L-KMT2A gene fusion in a paediatric B lymphoblastic leukaemia/lymphoma (B-ALL) patient.
Gestrich CK; Sadri N; Sinno MG; Pateva I; Meyerson HJ
Br J Haematol; 2020 Oct; 191(2):e61-e64. PubMed ID: 32729113
[No Abstract] [Full Text] [Related]
4. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
[TBL] [Abstract][Full Text] [Related]
5. Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.
Ferrari A; Ghelli Luserna Di Rora A; Domizio C; Papayannidis C; Simonetti G; Maria Hernández-Rivas J; Rondoni M; Giglio F; Abruzzese E; Imovilli A; Iacobucci I; Calistri D; Martinelli G
Br J Haematol; 2021 Mar; 192(6):e139-e144. PubMed ID: 33314053
[No Abstract] [Full Text] [Related]
6. A case of KMT2A-MLLT3 fusion-positive mature B-cell acute lymphoblastic leukemia.
Mitani Y; Arakawa Y; Mori M; Deguchi T; Koh K
Pediatr Int; 2021 Jun; 63(6):719-722. PubMed ID: 33871895
[No Abstract] [Full Text] [Related]
7.
Kato S; Kubota Y; Sekiguchi M; Watanabe K; Shinozaki-Ushiku A; Takita J; Hiwatari M
Pediatr Hematol Oncol; 2021 Apr; 38(3):281-289. PubMed ID: 33150819
[No Abstract] [Full Text] [Related]
8. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
[TBL] [Abstract][Full Text] [Related]
9. B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.
Kemps PG; Cleven AHG; van Wezel T; van Eijk R; Bot FJ; Veelken H; van Balen P; Kerkhoffs JH
Am J Hematol; 2020 Nov; 95(11):1427-1429. PubMed ID: 32243611
[No Abstract] [Full Text] [Related]
10. A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.
Yoshida M; Nakabayashi K; Ogata-Kawata H; Osumi T; Tsujimoto SI; Shirai R; Yoshida K; Okamura K; Matsumoto K; Kiyokawa N; Tomizawa D; Hata K; Kato M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27821. PubMed ID: 31115144
[No Abstract] [Full Text] [Related]
11. A case of
Forlenza CJ; Zhang Y; Yao J; Benayed R; Steinherz P; Ramaswamy K; Kessel R; Roshal M; Shukla N
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455225
[TBL] [Abstract][Full Text] [Related]
12. Estradiol induces gene proximity and MLL-MLLT3 fusion in an activation-induced cytidine deaminase-mediated pathway.
Wright RL; Slemmons KK; Vaughan AT
Leuk Lymphoma; 2015 May; 56(5):1460-5. PubMed ID: 25130479
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".
da Fonseca Bastos ACS; da Silva Rezende AC; Ferreira LB; Blunck CB; Pombo-de-Oliveira MS; Emerenciano M; Gimba ERP
Leuk Res; 2020 Apr; 91():106316. PubMed ID: 32114371
[No Abstract] [Full Text] [Related]
14. A Novel KMT2A-ARHGEF12 Fusion Gene Identified in a High-Grade B-cell Lymphoma.
Jung HS; Lin F; Wolpaw A; Reilly AF; Margolskee E; Luo M; Wertheim GB; Li MM
Cancer Genet; 2020 Aug; 246-247():41-43. PubMed ID: 32805689
[No Abstract] [Full Text] [Related]
15. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.
Haddox CL; Mangaonkar AA; Chen D; Shi M; He R; Oliveira JL; Litzow MR; Al-Kali A; Hogan WJ; Elliott MA
Blood Cancer J; 2017 Sep; 7(9):e607. PubMed ID: 29016570
[No Abstract] [Full Text] [Related]
16. Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine.
Chen X; Clark J; Wunderlich M; Fan C; Davis A; Chen S; Guan JL; Mulloy JC; Kumar A; Zheng Y
Autophagy; 2017 May; 13(5):955-966. PubMed ID: 28282266
[TBL] [Abstract][Full Text] [Related]
17. First case of B ALL with KMT2A-MAML2 rearrangement: a case report.
Menu E; Beaufils N; Usseglio F; Balducci E; Lafage Pochitaloff M; Costello R; Gabert J
BMC Cancer; 2017 May; 17(1):363. PubMed ID: 28535805
[TBL] [Abstract][Full Text] [Related]
18. A pediatric case of secondary T-cell acute lymphoblastic leukemia with KMT2A-MAML2 developing after hepatoblastoma treatment.
Takahashi Y; Terui K; Chinen Y; Tandai S; Kudo K; Sasaki S; Tono C; Taki T; Ito E
Pediatr Blood Cancer; 2020 Jan; 67(1):e28033. PubMed ID: 31599492
[No Abstract] [Full Text] [Related]
19. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]